Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Purpose: The purpose of this study is to examine the efficacy and safety of Fufangdanshen
Tablets in patients with mild to moderate vascular dementia (VaD).
Phase:
Phase 2
Details
Lead Sponsor:
Dongzhimen Hospital, Beijing
Collaborator:
Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited